The release of EVE from the liposome was evaluated by a dialysis method. In the preliminary experiment, the appearance of EVE in the outer buffer was not detected presumably because of its adsorption to the membrane, and therefore an inner sampling method 1,2) was adopted. Dialysis cassettes, Slide-A-Lyzer 7K MWCO (Thermo Scientific, Rockford, IL), were loaded with 1.5 mL of each liposome solution, and placed in 200 mL PBS under stirring condition at 37°C. At designated time points, a 50 μL sample was taken from the cassette, and replaced with an equal volume of fresh PBS to maintain the total volume. The samples were treated and quantified by LC-MS/MS in the same way as in the uptake experiment. The amount of EVE released was estimated from the decrease in concentration of EVE in the dialysis cassette. Figure S1 shows the release of EVE from EVE/PEG-and EVE/3'-CE sLeX mimic liposomes. The release profiles were biphasic, with an initial burst release followed by a slower release. The initialburst release of EVE appeared to be faster in EVE/3'-CE sLeX mimic liposomes than in EVE/PEGliposomes. No further analysis on the release kinetics was conducted, because discrimination between liposome-associated and liberated drug molecules was not guaranteed by the inner sampling.
S1. Drug release from liposome formulations
The release of EVE from the liposome was evaluated by a dialysis method. In the preliminary experiment, the appearance of EVE in the outer buffer was not detected presumably because of its adsorption to the membrane, and therefore an inner sampling method 1,2) was adopted. Dialysis cassettes, Slide-A-Lyzer 7K MWCO (Thermo Scientific, Rockford, IL), were loaded with 1.5 mL of each liposome solution, and placed in 200 mL PBS under stirring condition at 37°C. At designated time points, a 50 μL sample was taken from the cassette, and replaced with an equal volume of fresh PBS to maintain the total volume. The samples were treated and quantified by LC-MS/MS in the same way as in the uptake experiment. The amount of EVE released was estimated from the decrease in concentration of EVE in the dialysis cassette. Figure S1 shows the release of EVE from EVE/PEG-and EVE/3'-CE sLeX mimic liposomes. The release profiles were biphasic, with an initial burst release followed by a slower release. The initialburst release of EVE appeared to be faster in EVE/3'-CE sLeX mimic liposomes than in EVE/PEGliposomes. No further analysis on the release kinetics was conducted, because discrimination between liposome-associated and liberated drug molecules was not guaranteed by the inner sampling. Electronic Supplementary Material (ESI) for RSC Advances. This journal is © The Royal Society of Chemistry 2019
